健保藥品的HTA評估報告
- 41 喜繽果100毫克及200毫克膜衣錠 (Cibinqo 100mg、200mg film-coated tablets)
- 42 Galafold
- 43 Evrysdi Powder for Oral Solution, 0.75 mg/ml
- 44 德邁特膜衣錠 (TEPMETKO)
- 45 克瘤康膠囊 (Calquence Capsules)
- 46 PhosAdd Tab.
- 47 Spinraza Solution for injection
- 48 Evrysdi
- 49 Jyseleca 100 mg and 200 mg film-coated tablets
- 50 Xeljanz Film-Coated Tablets 5 mg、Xeljanz XR Extended Release Tablets 11 mg
- 51 修訂重度持續性氣喘治療藥品omalizumab 成分藥品(如Xolair)及嗜伊紅性(嗜酸性)白血球的嚴重氣喘治療藥品mepolizumab(如Nucala)、benralizumab(如Fasenra)
- 52 Rinvoq Extended-Release Tablets 15 mg
- 53 達珂凍晶注射劑 (Dacogen® Powder for Concentrate for Solution for Infusion)
- 54 Demylocan lyophilized powder for injection
- 55 Berinert
- 56 Chenodexycholic acid
- 57 EYBELIS ophthalmic solution
- 58 利腸服注射劑 (Revestive injection)
- 59 維萬心軟膠囊 (Vyndamax)
- 60 泰時維膜衣錠 (Ayvakit film-coated tablets)